Clobazam and diazepam in anxiety

Area of Science:

• Psychiatry and Pharmacology
• Clinical Psychology

Background:

• Anxiety disorders are prevalent, necessitating effective pharmacological treatments.
• Benzodiazepines are commonly prescribed for anxiety, but comparative efficacy requires further investigation.

Purpose of the Study:

• To compare the anxiolytic efficacy and side effect profiles of clobazam and diazepam against a placebo.
• To evaluate treatment outcomes in anxious outpatients within a family practice setting.

Main Methods:

• A 4-week, double-blind, placebo-controlled study involving 159 anxious outpatients.
• Administration of clobazam (30-80 mg/day) and diazepam (15-40 mg/day) with placebo as a control.
• Assessment of clinical improvement and side effects, primarily sedation.

Main Results:

• Both clobazam and diazepam showed greater clinical improvement than placebo.
• Clobazam induced the largest degree of improvement across most assessed aspects.
• Similar side effect profiles were observed for clobazam and diazepam, with sedation being the most common.

Conclusions:

• Clobazam and diazepam are effective anxiolytic agents for outpatients.
• Clobazam may offer superior efficacy compared to diazepam in certain anxiety symptom domains.
• Dosage considerations for diazepam might influence comparative effectiveness in clinical practice.